Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
BA2807 UNC0321Summary: UNC0321 is a potent and selective histone methyltransferase inhibitor. -
BA2809 SupinoxinSummary: Supinoxin (RX-5902) is a potent orally active inhibitor of phosphorylated p68RNA deconjugase and is the first antitumor reagent of its kind. -
BA2810 1A-116Summary: 1A-116 is an inhibitor specific for the W56 residue that effectively prevents the induced activation and blocks the interaction of the -
BA2811 BTSA1Summary: BTSA1 is a potent, high affinity and orally active activator. -
BA2813 TH1834Summary: TH1834 is a specific histone acetyltransferase inhibitor. -
BA2814 SKLB325Summary: SKLB325 is an inhibitor. -
BA2815 MitoBloCK-6Summary: MitoBloCK-6 is a potent inhibitor. -
BA2816 SSK1Summary: SSK1, a senescence-specific killing compound, is a β-galactosidase-targeting precursor that reduces inflammation. -
BA2817 Apostatin-1Summary: Apostatin-1 (Apt-1) is a potent inhibitor. -
BA2818 T025Summary: T025 is an orally effective inhibitor.


